AGY — Allergy Therapeutics Share News
0.000.00%
Last trade - 00:00- £706.27m
- £753.56m
- £55.04m
REG - AIM - AIM Notice - 05/10/2023
AnnouncementREG - Panmure Gordon (UK). Allergy Therapeutics - Form 8.5 (EPT/RI)
AnnouncementREG - Panmure Gordon (UK). Allergy Therapeutics - Form 8.5 (EPT/RI)
AnnouncementREG - Panmure Gordon (UK). Allergy Therapeutics - Form 8.5 (EPT/RI)
AnnouncementREG - Allergy Therapeutics - Block Listing Interim Review
AnnouncementREG - Panmure Gordon (UK). Allergy Therapeutics - Form 8.5 (EPT/RI)
AnnouncementREG - Panmure Gordon (UK). Allergy Therapeutics - Form 8.5 (EPT/RI)
AnnouncementREG - Cavendish Securities Allergy Therapeutics - Form 8.5 (EPT/NON-RI)
AnnouncementREG - Panmure Gordon (UK). Allergy Therapeutics - Form 8.5 (EPT/RI)
AnnouncementREG - Allergy Therapeutics - Publication of Open Offer Circular – Amendment
AnnouncementREG - Cavendish Securities Allergy Therapeutics - Form 8.5 (EPT/NON-RI)
AnnouncementREG - Allergy Therapeutics - Publication of Open Offer Circular
AnnouncementREG - Allergy Therapeutics - Unaudited Preliminary Results 2023
AnnouncementREG - Panmure Gordon (UK). Allergy Therapeutics - Form 8.5 (EPT/RI)
AnnouncementREG - Allergy Therapeutics - Phase I VLP Peanut PROTECT trial progress
AnnouncementREG - Panmure Gordon (UK). Allergy Therapeutics - Form 8.5 (EPT/RI)
AnnouncementREG - Cavendish Securities Allergy Therapeutics - Form 8.5 (EPT/NON-RI)
AnnouncementREG - Takeover Panel - Disclosure Table
AnnouncementREG - Panmure Gordon (UK). Allergy Therapeutics - Form 8.5 (EPT/RI)
Announcement